SOPHARMA AD: CONSOLIDATED FINANCIAL STATEMENTS FOR Q3 2016

opublikowano: 2016-11-29 14:48

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
SFARM_Group_Q3.zip  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 103 / 2016
Date of issue: 2016-11-29
Short name of the issuer
SOPHARMA AD
Subject
CONSOLIDATED FINANCIAL STATEMENTS FOR Q3 2016
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
CONSOLIDATED FINANCIAL STATEMENTS FOR Q3 2016

1. Financial Statements
2. Notes to the Financial Statements
3. Management report
4. Templates of the financial reports approved by the Bulgarian FSC
5. Declaration
6. Additional information
7. Annex 9
8. List of insider information
Annexes
File Description
SFARM_Group_Q3.zipSFARM_Group_Q3.zip CONSOLIDATED FINANCIAL STATEMENTS FOR Q3 2016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-11-29 Ognian Donev Executive director